Original Report

Information and communication needs of Chinese American breast cancer patients: perspectives on survivorship care planning


 

Background The existing knowledge on the survivorship experiences of Chinese American breast cancer survivors (CABCS) has arisen largely from aggregated data across multiethnic or multicancer studies that have focused on quality of life. Little is known about Chinese American perspectives and preferences for survivorship care.

Objective To examine the experiences of CABCS to better understand their information and communication needs and their preferences for survivorship care plans (SCPs).

Methods 16 CABCS, aged 37-72 years, were recruited through community-based organizations in the Northeast United States to participate in one-on-one telephone interviews about their breast cancer survivorship experience. The semistructured interviews were conducted in Mandarin, Cantonese, or English. Two investigators transcribed and translated the audio recordings into English and analyzed the interview transcripts using established methods of qualitative content analysis.

Results Three main themes were identified through analysis of interview transcripts: the need for evidence-based and culturally and linguistically appropriate health information; the role of language or communication barriers and culture in accessing care and communicating with providers; and preferences for SCP elements and format.

Limitations The sample may not be representative of the entire population of CABCS.

Conclusions The findings provide insight into the information and communication needs and SCP preferences of CABCS. Understanding the cultural nuances that underlie these needs and preferences is critical for improving CABCS’s quality of life after treatment for cancer. SCPs that incorporate Chinese-language resources and address the unique cultural needs of this population should be developed and they should include information about diet and nutrition as well as traditional Chinese medicine.

Funding This work was supported in part by the NIH-NCI’s Community Network Program Center, ACCHDC (U54CA153513, PI: Dr Grace Ma) and P30 CA06927.

Click on the PDF icon at the top of this introduction to read the full article.

Recommended Reading

VIDEO: First report of immune checkpoint inhibitor treatment for breast cancer
MDedge Hematology and Oncology
VIDEO: Multidisciplinary panel addresses role of anesthesia, analgesics in patient outcomes
MDedge Hematology and Oncology
SOFT trial endorses selective ovarian suppression in early breast cancer
MDedge Hematology and Oncology
VIDEO: Dr. Prudence Francis describes how SOFT results will change practice
MDedge Hematology and Oncology
VIDEO: What was the most interesting thing you learned at the meeting?
MDedge Hematology and Oncology
20 years after initiating preventive tamoxifen, less breast cancer but no survival benefit
MDedge Hematology and Oncology
VIDEO: What have we learned about prevention of breast cancer from IBIS-1?
MDedge Hematology and Oncology
AI-induced symptoms don’t predict survival
MDedge Hematology and Oncology
Acupuncture beats gabapentin for hot flashes in RCT
MDedge Hematology and Oncology
Genetic test predicts 10-year risk of DCIS recurrence
MDedge Hematology and Oncology